BlackRock Future Health ETF
BMED
3 hedge funds and large institutions have $753K invested in BlackRock Future Health ETF in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
15% more capital invested
Capital invested by funds: $657K → $753K (+$96.4K)
1.59% more ownership
Funds ownership: 11.8% → 13.39% (+1.6%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$105K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$9.77K |
| 2 |
Jane Street
New York
|
-$5.55K |
BMED Hedge Fund Activity: Q1 2023 in Review
3 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in BlackRock Future Health ETF (BMED) for Q1 2023, worth a combined $753K — up 15% from $657K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BMED and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $105K. The largest seller was UBS Group, exiting entirely with an estimated $9.77K sold.
- 3 institutional investors held BlackRock Future Health ETF (BMED) as of Q1 2023, down from 4 in Q4 2022.
- Funds reported $753K of BlackRock Future Health ETF stock for Q1 2023, up 15% quarter-over-quarter.
- 0 funds opened new BlackRock Future Health ETF positions in Q1 2023 and 1 closed out, a net change of -1 holder.
- The largest BlackRock Future Health ETF buyer in Q1 2023 was Citadel Advisors, an estimated $105K added.
- The largest BlackRock Future Health ETF seller in Q1 2023 was UBS Group, an estimated $9.77K sold.
Based on aggregated 13F filings for Q1 2023.